Dr. Grimm is a part of the Medical Faculty at the University of Heidelberg, teaching about viral vector technologies. He leads the Grimm Lab at the university and has also received the Outstanding Achievement Award from the Dutch Society of Gene and Cell Therapy (2020) and a Research Award from the German Duchenne Foundation (2017). Dr. Grimm has notable research interests in the creation and use of synthetic AAV vectors for human gene therapy and CRISPR/Cas systems and zinc finger nucleases.
.png)
